Aurobindo Pharma ties up with BIRAC to develop COVID-19 vaccine
ABLE Member and Hyderabad-headquartered pharma major Aurobindo Pharma announced collaboration with the Biotechnology Industry Research Assistance Council (BIRAC), set up by the Department of Biotechnology for the development of COVID-19 vaccine.
“Biological E can make a billion doses of the vaccine a year,” Dr Maria Elena Bottazzi, associate dean, BCM National School of Tropical Medicine
In an interview to The Indian Express, Dr Maria Elena Bottazzi, said that Hyderabad-headquartered vaccine maker Biological E can help scale up production of an affordable Covid-19 vaccine.
Serum Institute of India gets DCGI nod to resume clinical trial of Oxford Covid-19 vaccine
SII, which has partnered with AstraZeneca for manufacturing the vaccine candidate for Covid-19, on September 15 submitted the recommendations of the Data and Safety Monitoring Board (DSMB), UK and DSMB, India, and requested for permission to restart enrolment in the clinical trial of the Covid Vaccine.
Dr. Reddy’s signs MoU to receive 100 million doses of Russian Covid Vaccine Sputnik V vaccine
The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and ABLE member, Dr. Reddy’s Laboratories Ltd (Dr. Reddy’s) have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India.